C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
06/2011
06/30/2011	WO2011076765A1 Novel antiviral compounds
06/30/2011	WO2011076327A1 Pyrrolo[2,3-d]pyrazin-7-yl pyrimidine compounds
06/30/2011	WO2011019986A3 Processes for preparing pemetrexed
06/30/2011	WO2011013992A3 R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial
06/30/2011	WO2010110685A4 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
06/30/2011	US20110160451 2-Aminopyrimidine modulators of the histamine H4 receptor
06/30/2011	US20110160450 Explosive
06/30/2011	US20110160243 Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
06/30/2011	US20110160226 Substituted Triazolo-Pyrimidine Compounds
06/30/2011	US20110160222 Modulators of glucose homeostasis for the treatment of diabetes and metabolic disorders
06/30/2011	US20110160215 Substituted Triazolo-Pyrazine Compounds
06/30/2011	US20110160210 Control of intraocular pressure using alk5 modulation agents
06/30/2011	US20110160208 Diaryl-substituted five-membered heterocycle derivative
06/30/2011	US20110160207 Heterocyclic amide compounds useful as kinase inhibitors
06/30/2011	US20110160203 Substituted Pyrrolo-Aminopyrimidine Compounds
06/30/2011	US20110160192 Biaryl amino acids and their use in dna binding oligomers
06/30/2011	US20110160191 New fused polycyclic compounds having a heterocyclic ring(s) and pharmaceutical use thereof
06/30/2011	US20110160185 Pyrrolopyrimidine derivatives as jak3 inhibitors
06/30/2011	US20110160183 Inhibitors of akt activity
06/30/2011	US20110160182 Pyrazine compounds as phosphodiesterase 10 inhibitors
06/30/2011	US20110160177 Novel carbapenem derivatives
06/30/2011	US20110158989 Poly (ADP-Ribose) Polymerase (PARP) INHIBITORS
06/30/2011	US20110155973 Improved, red colour filter composition
06/30/2011	DE102009060175A1 Pyrrolo[2,3-d] pyrazin-7-yl-pyrimidin-Verbindungen Pyrrolo [2,3-d] pyrazin-7-yl-pyrimidine compounds
06/30/2011	CA2786950A1 Fused heteroaromatic pyrrolidinones as syk inhibitors
06/30/2011	CA2785329A1 Pyrrolo[2,3-d]pyrazin-7-ylpyrimidine compounds
06/30/2011	CA2784180A1 Seven-membered ring compound and pharmaceutical use therefor
06/30/2011	CA2783575A1 Aminopyrimidine kinase inhibitors
06/30/2011	CA2781780A1 Novel antiviral compounds
06/29/2011	EP2338925A1 -electron conjugated compound, manufacturing method therefor, and -electron conjugated polymer obtained using same
06/29/2011	EP2338890A1 4,7-Diazaindole derivatives and their use as fungicides
06/29/2011	EP2338889A1 Diazacyclic compounds having affinity for opioid receptors
06/29/2011	EP2338491A2 Pharmaceutical composition comprising a beta-carboline
06/29/2011	EP2089394B1 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
06/29/2011	CN102112478A 5H-pyrr0l0 [2, 3-B] pyrazine derivatives for kinase modulation, and indications therefor
06/29/2011	CN102112475A Imidazopyridine and related analogs as sirtuin modulators
06/29/2011	CN102112442A Process for preparation of macrocycle
06/29/2011	CN102110785A Double layer hardmask for organic devices
06/29/2011	CN101243088B P38 map kinase inhibitors and methods for using the same
06/28/2011	US7968752 Hydrolytically-resistant boron-containing therapeutics and methods of use
06/28/2011	US7968719 Indazole derivatives as inhibitors of hormone sensitive lipase
06/28/2011	US7968716 Caspase inhibitors and uses thereof
06/28/2011	US7968706 Method of manufacturing phthalocyanine compound
06/28/2011	US7968557 Diseases with abnormal activation of the Abl, BCR-Abl, Bmx, CSK, TrkB, FGFR3, Fes, Lck, B-RAF, C-RAF, MKK6, alpha and beta SAPK2 kinases; antiproliferative; pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-phenylcarbamoyl-phenyl]-amides and pyrrolo[3,2-c]pyridine analogs
06/28/2011	US7968556 Heteroaryl compounds, compositions thereof, and methods of treatment therewith
06/28/2011	US7968554 Pyrazolo[3,4-d]pyrimidine derivatives
06/28/2011	US7968553 Tetrahydro-4H-pyrido[1,2-a] pyrimidines useful as HIV integrase inhibitors
06/28/2011	US7968540 Spirohydantoin tricyclic CGRP receptor antagonists
06/28/2011	CA2602248C Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
06/28/2011	CA2496241C 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
06/28/2011	CA2494700C Calcium receptor modulating compound and use thereof
06/28/2011	CA2445834C Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands
06/28/2011	CA2427206C Sulfamides as gamma-secretase inhibitors
06/23/2011	WO2011075699A2 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
06/23/2011	WO2011075615A1 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
06/23/2011	WO2011075565A1 SUBSTITUTED AMINOTHIAZOLONE INDAZOLES AS ESTROGEN RELATED RECEPTOR-Aα MODULATORS
06/23/2011	WO2011075487A1 Bridgehead amine ring -fused indoles and indolines useful to treat neurodegenerative and neuropsychiatry disorders
06/23/2011	WO2011075383A1 Inhibitors of akt activity
06/23/2011	WO2011075334A1 Pyrrolo[2,3-d]pyrimidine compounds
06/23/2011	WO2011074677A1 Imidazopyrimidine derivative or salt thereof, and noxious organism control agent comprising same
06/23/2011	WO2011073172A1 Ethynyl derivatives
06/23/2011	WO2011072696A1 2-arylimidazole derivatives as pde10a enzyme inhibitors
06/23/2011	WO2011072695A1 Phenylimidazole derivatives comprising an ethynylene linker as pde10a enzyme inhibitors
06/23/2011	WO2011072694A1 Heteroaromatic phenylimidazole derivatives as pde10a enzyme inhibitors
06/23/2011	WO2011014520A3 Compounds and compositions as modulators of gpr119 activity
06/23/2011	US20110152562 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING a-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME
06/23/2011	US20110152518 Cycloalkyl Substituted Pyrimidinediamine Compounds And Their Uses
06/23/2011	US20110152515 New route to formyl-porphyrins
06/23/2011	US20110152310 Tricyclic triazole compounds that modulate hsp90 activity
06/23/2011	US20110152306 Aza-bridged ring-fused indoles and indolines
06/23/2011	US20110152298 Imidazo [2,1-b] quinazolin-2-one derivatives and their use as platelet anti-aggregative agents
06/23/2011	US20110152278 Synthesis and anti-proliferative effect of benzimidazole derivatives
06/23/2011	US20110152277 Heterocyclic compounds and their uses
06/23/2011	US20110152273 Fused heteroaromatic pyrrolidinones
06/23/2011	US20110152258 Compounds and Methods for Kinase Modulation, and Indications Therefor
06/23/2011	US20110152257 Ethynyl compounds useful for treatment of cns disorders
06/23/2011	US20110152256 1,2,4-TRIAZOLO[4,3-c]PYRIMIDIN-3-ONE AND PYRAZOLO[4,3-e]-1,2,4-TRIAZOLO[4,3-c]PYRIMIDIN-3-ONE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
06/23/2011	US20110152248 Bridgehead amine ring-fused indoles and indolines
06/23/2011	US20110152244 Pyrrolopyrimidine compounds and their uses
06/23/2011	US20110152243 Novel thienopyrrole compounds
06/23/2011	US20110152240 Pyrazolopyrimidines and related heterocycles as ck2 inhibitors
06/23/2011	US20110152238 Pharmaceutical compounds
06/23/2011	US20110152237 Chemical Compounds
06/23/2011	US20110152234 Novel Compounds
06/23/2011	US20110151615 Bicyclic guanidines, metal complexes thereof and their use in vapor deposition
06/23/2011	US20110150864 Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators
06/23/2011	US20110150835 Macrocyclic Inhibitors of Hepatitis C Virus NS3 Serine Protease
06/23/2011	US20110150827 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
06/23/2011	US20110149393 Polycyclic Organic Compounds, Polarizing Elements and Method of Production Thereof
06/23/2011	US20110147727 Oleds doped with phosphorescent compounds
06/23/2011	CA2784830A1 Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
06/23/2011	CA2784753A1 Substituted aminothiazolone indazoles as estrogen related receptor-.alpha. modulators
06/23/2011	CA2784748A1 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
06/23/2011	CA2783726A1 Heteroaromatic phenylimidazole derivatives as pde10a enzyme inhibitors
06/23/2011	CA2782720A1 Pyrrolo[2,3-d]pyrimidine compounds
06/23/2011	CA2782361A1 Bridgehead amine ring-fused indoles and indolines useful to treat neurodegenerative and neuropsychiatric disorders
06/23/2011	CA2781390A1 Bridged bicyclic rho kinase inhibitor compounds, composition and use
06/23/2011	CA2780155A1 Ethynyl derivatives
06/22/2011	EP2336136A1 Pyridine derivatives and their use in the treatment of psychotic disorders
06/22/2011	EP2336123A2 Heterocyclic compound as protein kinase inhibitor

1 ... 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 ... 573